CSI Market
Sign In | Register

Genomic Health Inc (GHDX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GHDX Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Genomic Health Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2019)
9 Months 		(Jun 30 2019) (Mar 31 2019) (Dec 31 2018) (Sep 30 2018)
Operating Activities
Income47.68
Depreciation & amortization9.87
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets to be Disposed of4.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.75
Share-based Compensation19.45
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Write Off Of Previously Capitalized Costs-
Available For Sale Securities Gross Realized Gains-
Investment Income Net Amortization Of Discount And Premium-
Capitalized Computer Software Impairments-
Equity Securities Fv Ni Realized Gain-
Debt Securities Available For Sale Realized Gain Loss-0.01
Increase Decrease In Contract With Customer Liability-0.12
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-6.87
Increase (Decrease) in Accounts Payable-2.46
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-3.94
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.45
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.91
Discontinued operations0.00
Net Cash flow from Operating Activities66.88
Investing Activities
Capital Expenditures-16.00
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt23.31
Payments to Acquire Marketable Securities-224.91
Real Estate Investments0.00
Proceeds From Maturity Of Marketable Securities149.22
Proceeds From Sale Of Marketable Securities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-68.37
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock24.13
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-12.17
Finance Lease Principal Payments-0.16
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities11.80
Effect of exchange rate on cash flow10.31
Discontinued operations0.00
Free Cash Flow50.88
Total Cash Flow10.31
4 historic quarters locked

Sign in to unlock the full Genomic Health Inc cash flow history.

Sign In Create Free Account

About GHDX Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.